Overview

Allopurinol for Renal Transplant Associated Hypertension in Children

Status:
Withdrawn
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
To test the hypothesis that lowering serum uric acid will ameliorate hypertension in children after renal transplantation.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator:
Baylor University
Treatments:
Allopurinol